nodes	percent_of_prediction	percent_of_DWPC	metapath
Entecavir—Decompensated cirrhosis—Furosemide—dilated cardiomyopathy	0.4	0.4	CcSEcCtD
Entecavir—Hepatic encephalopathy—Furosemide—dilated cardiomyopathy	0.0954	0.0954	CcSEcCtD
Entecavir—Hepatic cirrhosis—Furosemide—dilated cardiomyopathy	0.0722	0.0722	CcSEcCtD
Entecavir—Glycosuria—Furosemide—dilated cardiomyopathy	0.0171	0.0171	CcSEcCtD
Entecavir—Serum creatinine increased—Lisinopril—dilated cardiomyopathy	0.0169	0.0169	CcSEcCtD
Entecavir—Renal failure—Spironolactone—dilated cardiomyopathy	0.014	0.014	CcSEcCtD
Entecavir—Alopecia—Spironolactone—dilated cardiomyopathy	0.0113	0.0113	CcSEcCtD
Entecavir—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.0104	0.0104	CcSEcCtD
Entecavir—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00995	0.00995	CcSEcCtD
Entecavir—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00941	0.00941	CcSEcCtD
Entecavir—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00908	0.00908	CcSEcCtD
Entecavir—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00851	0.00851	CcSEcCtD
Entecavir—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00839	0.00839	CcSEcCtD
Entecavir—Somnolence—Spironolactone—dilated cardiomyopathy	0.00807	0.00807	CcSEcCtD
Entecavir—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00783	0.00783	CcSEcCtD
Entecavir—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00783	0.00783	CcSEcCtD
Entecavir—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00779	0.00779	CcSEcCtD
Entecavir—Renal failure—Furosemide—dilated cardiomyopathy	0.00761	0.00761	CcSEcCtD
Entecavir—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00732	0.00732	CcSEcCtD
Entecavir—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00717	0.00717	CcSEcCtD
Entecavir—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00706	0.00706	CcSEcCtD
Entecavir—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00639	0.00639	CcSEcCtD
Entecavir—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00628	0.00628	CcSEcCtD
Entecavir—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00621	0.00621	CcSEcCtD
Entecavir—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00609	0.00609	CcSEcCtD
Entecavir—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00605	0.00605	CcSEcCtD
Entecavir—Malnutrition—Furosemide—dilated cardiomyopathy	0.00605	0.00605	CcSEcCtD
Entecavir—Dizziness—Spironolactone—dilated cardiomyopathy	0.006	0.006	CcSEcCtD
Entecavir—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00588	0.00588	CcSEcCtD
Entecavir—Vomiting—Spironolactone—dilated cardiomyopathy	0.00577	0.00577	CcSEcCtD
Entecavir—Rash—Spironolactone—dilated cardiomyopathy	0.00572	0.00572	CcSEcCtD
Entecavir—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00572	0.00572	CcSEcCtD
Entecavir—Renal failure—Lisinopril—dilated cardiomyopathy	0.00571	0.00571	CcSEcCtD
Entecavir—Headache—Spironolactone—dilated cardiomyopathy	0.00569	0.00569	CcSEcCtD
Entecavir—Haematuria—Lisinopril—dilated cardiomyopathy	0.00554	0.00554	CcSEcCtD
Entecavir—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00549	0.00549	CcSEcCtD
Entecavir—Leukopenia—Furosemide—dilated cardiomyopathy	0.00542	0.00542	CcSEcCtD
Entecavir—Nausea—Spironolactone—dilated cardiomyopathy	0.00539	0.00539	CcSEcCtD
Entecavir—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00521	0.00521	CcSEcCtD
Entecavir—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00514	0.00514	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00511	0.00511	CcSEcCtD
Entecavir—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00494	0.00494	CcSEcCtD
Entecavir—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00484	0.00484	CcSEcCtD
Entecavir—Skin disorder—Furosemide—dilated cardiomyopathy	0.0048	0.0048	CcSEcCtD
Entecavir—Alopecia—Lisinopril—dilated cardiomyopathy	0.00461	0.00461	CcSEcCtD
Entecavir—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00457	0.00457	CcSEcCtD
Entecavir—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00454	0.00454	CcSEcCtD
Entecavir—Somnolence—Furosemide—dilated cardiomyopathy	0.00439	0.00439	CcSEcCtD
Entecavir—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00426	0.00426	CcSEcCtD
Entecavir—Fatigue—Furosemide—dilated cardiomyopathy	0.00426	0.00426	CcSEcCtD
Entecavir—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00406	0.00406	CcSEcCtD
Entecavir—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00404	0.00404	CcSEcCtD
Entecavir—Abdominal pain—Furosemide—dilated cardiomyopathy	0.0039	0.0039	CcSEcCtD
Entecavir—Body temperature increased—Furosemide—dilated cardiomyopathy	0.0039	0.0039	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00384	0.00384	CcSEcCtD
Entecavir—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.0037	0.0037	CcSEcCtD
Entecavir—Infection—Lisinopril—dilated cardiomyopathy	0.00368	0.00368	CcSEcCtD
Entecavir—Skin disorder—Lisinopril—dilated cardiomyopathy	0.0036	0.0036	CcSEcCtD
Entecavir—Asthenia—Furosemide—dilated cardiomyopathy	0.00354	0.00354	CcSEcCtD
Entecavir—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00338	0.00338	CcSEcCtD
Entecavir—Insomnia—Lisinopril—dilated cardiomyopathy	0.00335	0.00335	CcSEcCtD
Entecavir—Somnolence—Lisinopril—dilated cardiomyopathy	0.00329	0.00329	CcSEcCtD
Entecavir—Dizziness—Furosemide—dilated cardiomyopathy	0.00326	0.00326	CcSEcCtD
Entecavir—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00326	0.00326	CcSEcCtD
Entecavir—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.0032	0.0032	CcSEcCtD
Entecavir—Fatigue—Lisinopril—dilated cardiomyopathy	0.00319	0.00319	CcSEcCtD
Entecavir—Vomiting—Furosemide—dilated cardiomyopathy	0.00314	0.00314	CcSEcCtD
Entecavir—Rash—Furosemide—dilated cardiomyopathy	0.00311	0.00311	CcSEcCtD
Entecavir—Dermatitis—Furosemide—dilated cardiomyopathy	0.00311	0.00311	CcSEcCtD
Entecavir—Headache—Furosemide—dilated cardiomyopathy	0.00309	0.00309	CcSEcCtD
Entecavir—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00303	0.00303	CcSEcCtD
Entecavir—Nausea—Furosemide—dilated cardiomyopathy	0.00293	0.00293	CcSEcCtD
Entecavir—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00293	0.00293	CcSEcCtD
Entecavir—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00293	0.00293	CcSEcCtD
Entecavir—Asthenia—Lisinopril—dilated cardiomyopathy	0.00266	0.00266	CcSEcCtD
Entecavir—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00253	0.00253	CcSEcCtD
Entecavir—Dizziness—Lisinopril—dilated cardiomyopathy	0.00245	0.00245	CcSEcCtD
Entecavir—Vomiting—Lisinopril—dilated cardiomyopathy	0.00236	0.00236	CcSEcCtD
Entecavir—Rash—Lisinopril—dilated cardiomyopathy	0.00234	0.00234	CcSEcCtD
Entecavir—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00233	0.00233	CcSEcCtD
Entecavir—Headache—Lisinopril—dilated cardiomyopathy	0.00232	0.00232	CcSEcCtD
Entecavir—Nausea—Lisinopril—dilated cardiomyopathy	0.0022	0.0022	CcSEcCtD
